-
1
-
-
10044285942
-
Cardiovascular risk in peritoneal dialysis
-
S. Prichard Cardiovascular risk in peritoneal dialysis Contrib Nephrol 140 2003 82 90
-
(2003)
Contrib Nephrol
, vol.140
, pp. 82-90
-
-
Prichard, S.1
-
2
-
-
0028046085
-
Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis
-
N. Lameire, P. Bernaert, M.-C. Lambert, and D. Vijt Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis Kidney Int 46 Suppl. 48 1994 S31 S38
-
(1994)
Kidney Int
, vol.46
, Issue.SUPPL. 48
-
-
Lameire, N.1
Bernaert, P.2
Lambert, M.-C.3
Vijt, D.4
-
3
-
-
4243159858
-
Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease
-
G. Buccianti, I. Baragetti, F. Barmonti, S. Furiani, V. Dorighet, and C. Patrosso Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease J Nephrol 17 2004 405 410
-
(2004)
J Nephrol
, vol.17
, pp. 405-410
-
-
Buccianti, G.1
Baragetti, I.2
Barmonti, F.3
Furiani, S.4
Dorighet, V.5
Patrosso, C.6
-
4
-
-
13444251648
-
Homocysteine in uraemia - A puzzling and conflicting story
-
M.E. Suliman, P. Barany, K. Kalantar-Zadeh, B. Lindholm, and P. Stenvinkel Homocysteine in uraemia - a puzzling and conflicting story Nephrol Dial Transplant 20 2005 16 21
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 16-21
-
-
Suliman, M.E.1
Barany, P.2
Kalantar-Zadeh, K.3
Lindholm, B.4
Stenvinkel, P.5
-
5
-
-
68849101346
-
Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: A meta-analysis
-
J. Heinz, S. Kropf, C. Luley, and J. Dierkes Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis Am J Kidney Dis 54 2009 478 489
-
(2009)
Am J Kidney Dis
, vol.54
, pp. 478-489
-
-
Heinz, J.1
Kropf, S.2
Luley, C.3
Dierkes, J.4
-
6
-
-
0033620779
-
Homocysteine and vascular disease
-
G.J. Hankey, and J.W. Eikelboom Homocysteine and vascular disease Lancet 354 1999 407 413
-
(1999)
Lancet
, vol.354
, pp. 407-413
-
-
Hankey, G.J.1
Eikelboom, J.W.2
-
7
-
-
0036379621
-
C-reactive protein and cardiovascular disease in peritoneal dialysis patients
-
D. Ducloux, C. Bresson-Vautrin, M. Kribs, A. Abdelfatah, and J.M. Chalopin C-reactive protein and cardiovascular disease in peritoneal dialysis patients Kidney Int 62 2002 1417 1422
-
(2002)
Kidney Int
, vol.62
, pp. 1417-1422
-
-
Ducloux, D.1
Bresson-Vautrin, C.2
Kribs, M.3
Abdelfatah, A.4
Chalopin, J.M.5
-
8
-
-
77950916697
-
The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients
-
S. Ertek, A.N. Torun, and K. Ates The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients Int Urol Nephrol 42 2010 211 218
-
(2010)
Int Urol Nephrol
, vol.42
, pp. 211-218
-
-
Ertek, S.1
Torun, A.N.2
Ates, K.3
-
9
-
-
7144226583
-
Major determinants of hyperhomocysteinemia in peritoneal dialysis patients
-
A. Vychytil, M. Födinger, G. Wölfl, B. Enzenberger, M. Auinger, F. Prischl, M. Buxbaum, M. Wiesholzer, C. Mannhalter, W.H. Hörl, and G. Sunder-Plassmann Major determinants of hyperhomocysteinemia in peritoneal dialysis patients Kidney Int 53 1998 1775 1782
-
(1998)
Kidney Int
, vol.53
, pp. 1775-1782
-
-
Vychytil, A.1
Födinger, M.2
Wölfl, G.3
Enzenberger, B.4
Auinger, M.5
Prischl, F.6
Buxbaum, M.7
Wiesholzer, M.8
Mannhalter, C.9
Hörl, W.H.10
Sunder-Plassmann, G.11
-
10
-
-
16244382834
-
Circulating soluble vascular cell adhesion molecule 1: Relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients
-
A.Y. Wang, C.W. Lam, M. Wang, J. Woo, I.H. Chan, S.F. Lui, J.E. Sanderson, and P.K. Li Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients Am J Kidney Dis 45 2005 715 729
-
(2005)
Am J Kidney Dis
, vol.45
, pp. 715-729
-
-
Wang, A.Y.1
Lam, C.W.2
Wang, M.3
Woo, J.4
Chan, I.H.5
Lui, S.F.6
Sanderson, J.E.7
Li, P.K.8
-
11
-
-
33747819235
-
Crucial role of interferon-γ and stimulated macrophages in cardiovascular disease
-
K. Schroecksnadel, B. Frick, C. Winkler, and D. Fusch Crucial role of interferon-γ and stimulated macrophages in cardiovascular disease Curr Vasc Pharmacol 4 2006 205 213
-
(2006)
Curr Vasc Pharmacol
, vol.4
, pp. 205-213
-
-
Schroecksnadel, K.1
Frick, B.2
Winkler, C.3
Fusch, D.4
-
12
-
-
0027486072
-
Neuropharmacology of quinolinic and kynurenic acids
-
T.W. Stone Neuropharmacology of quinolinic and kynurenic acids Pharmacol Rev 45 1993 309 379
-
(1993)
Pharmacol Rev
, vol.45
, pp. 309-379
-
-
Stone, T.W.1
-
13
-
-
67349241663
-
The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease
-
K. Pawlak, T. Domaniewski, M. Mysliwiec, and D. Pawlak The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease Atherosclerosis 204 2009 309 314
-
(2009)
Atherosclerosis
, vol.204
, pp. 309-314
-
-
Pawlak, K.1
Domaniewski, T.2
Mysliwiec, M.3
Pawlak, D.4
-
14
-
-
67349118403
-
Kynurenine, quinolinic acid - The new factors linked to carotid atherosclerosis in patients with end-stage renal disease
-
K. Pawlak, S. Brzosko, M. Mysliwiec, and D. Pawlak Kynurenine, quinolinic acid - The new factors linked to carotid atherosclerosis in patients with end-stage renal disease Atherosclerosis 204 2009 561 566
-
(2009)
Atherosclerosis
, vol.204
, pp. 561-566
-
-
Pawlak, K.1
Brzosko, S.2
Mysliwiec, M.3
Pawlak, D.4
-
15
-
-
76449091049
-
Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients
-
K. Pawlak, M. Mysliwiec, and D. Pawlak Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients Thromb Res 125 2010 e40 e45
-
(2010)
Thromb Res
, vol.125
-
-
Pawlak, K.1
Mysliwiec, M.2
Pawlak, D.3
-
16
-
-
12144286859
-
Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor
-
K. Wejksza, W. Rzeski, J. Parada-Turska, B. Zdzisinska, R. Rejdak, T. Kocki, E. Okuno, M. Kandefer-Szerszen, E. Zrenner, and W.A. Turski Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor Naunyn Schmiedebergs Arch Pharmacol 369 2004 300 304
-
(2004)
Naunyn Schmiedebergs Arch Pharmacol
, vol.369
, pp. 300-304
-
-
Wejksza, K.1
Rzeski, W.2
Parada-Turska, J.3
Zdzisinska, B.4
Rejdak, R.5
Kocki, T.6
Okuno, E.7
Kandefer-Szerszen, M.8
Zrenner, E.9
Turski, W.A.10
-
17
-
-
22144446744
-
Homocysteine, a risk factor for atherosclerosis, biophasically changes the endothelial production of kynurenic acid
-
J. Stazka, P. Luchowski, and E.M. Urbanska Homocysteine, a risk factor for atherosclerosis, biophasically changes the endothelial production of kynurenic acid Eur J Pharmacol 517 2005 217 223
-
(2005)
Eur J Pharmacol
, vol.517
, pp. 217-223
-
-
Stazka, J.1
Luchowski, P.2
Urbanska, E.M.3
-
18
-
-
70549088032
-
Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells
-
K. Wejksza, W. Rzeski, and W.A. Turski Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells Pharmacol Rep 61 2009 751 756
-
(2009)
Pharmacol Rep
, vol.61
, pp. 751-756
-
-
Wejksza, K.1
Rzeski, W.2
Turski, W.A.3
-
19
-
-
33748647647
-
Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: A study in stroke patients
-
E.M. Urbanska, P. Luchowski, E. Luchowska, J. Pniewski, R. Wozniak, M. Chodakowska-Zebrowska, and J. Lazareicz Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: a study in stroke patients Pharmacol Rep 58 2006 507 511
-
(2006)
Pharmacol Rep
, vol.58
, pp. 507-511
-
-
Urbanska, E.M.1
Luchowski, P.2
Luchowska, E.3
Pniewski, J.4
Wozniak, R.5
Chodakowska-Zebrowska, M.6
Lazareicz, J.7
-
20
-
-
0036184490
-
Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure
-
D. Pawlak, A. Tankiewicz, P. Mysliwiec, and W. Buczko Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure Nephron 90 2002 328 335
-
(2002)
Nephron
, vol.90
, pp. 328-335
-
-
Pawlak, D.1
Tankiewicz, A.2
Mysliwiec, P.3
Buczko, W.4
-
21
-
-
18044400553
-
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
-
K.B. Holven, T. Holm, P. Aukrust, B. Christensen, J. Kjekshus, A.K. Andreassen, L. Gullestad, T.A. Hagve, A. Svilaas, L. Ose, and M.S. Nenseter Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects Am J Med 110 2001 536 542
-
(2001)
Am J Med
, vol.110
, pp. 536-542
-
-
Holven, K.B.1
Holm, T.2
Aukrust, P.3
Christensen, B.4
Kjekshus, J.5
Andreassen, A.K.6
Gullestad, L.7
Hagve, T.A.8
Svilaas, A.9
Ose, L.10
Nenseter, M.S.11
-
22
-
-
13344270367
-
Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells
-
J.C. Tsai, H. Wang, M.A. Perrella, M. Yoshizumi, N.E. Sibinga, L.C. Tan, E. Haber, T.H. Chang, R. Schlegel, and M.E. Lee Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells J Clin Invest 97 1996 146 153
-
(1996)
J Clin Invest
, vol.97
, pp. 146-153
-
-
Tsai, J.C.1
Wang, H.2
Perrella, M.A.3
Yoshizumi, M.4
Sibinga, N.E.5
Tan, L.C.6
Haber, E.7
Chang, T.H.8
Schlegel, R.9
Lee, M.E.10
-
23
-
-
0035478066
-
The brain metabolite kynurenic acid metabolite inhibits alpha 7 nicotinic receptor activity and increases non-alpha 7 nicotinic receptor expression: Physiopathological implications
-
C. Hilmas, E.F. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E.X. Albuquerque The brain metabolite kynurenic acid metabolite inhibits alpha 7 nicotinic receptor activity and increases non-alpha 7 nicotinic receptor expression: physiopathological implications J Neurosci 21 2001 7463 7473
-
(2001)
J Neurosci
, vol.21
, pp. 7463-7473
-
-
Hilmas, C.1
Pereira, E.F.2
Alkondon, M.3
Rassoulpour, A.4
Schwarcz, R.5
Albuquerque, E.X.6
-
24
-
-
21044433581
-
Identification of homocysteine receptor in the peripheral endothelium and its role in proliferation
-
H. Chen, B.S. Fitzgerald, A.T. Brown, I. Qureshi, J. Breckenridge, R. Kazi, Y. Wang, Y. Wu, X. Zhang, P. Mukunyadzi, J. Edit, and M.M. Moursi Identification of homocysteine receptor in the peripheral endothelium and its role in proliferation J Vasc Surg 41 2005 853 860
-
(2005)
J Vasc Surg
, vol.41
, pp. 853-860
-
-
Chen, H.1
Fitzgerald, B.S.2
Brown, A.T.3
Qureshi, I.4
Breckenridge, J.5
Kazi, R.6
Wang, Y.7
Wu, Y.8
Zhang, X.9
Mukunyadzi, P.10
Edit, J.11
Moursi, M.M.12
|